NEW YORK (360Dx) – Quidel announced on Tuesday it has completed the acquisition of the InflammaDry and AdenoPlus diagnostic businesses from point-of-care eye health diagnostics manufacturer RPS Diagnostics for approximately $14 million in cash.

The two businesses consist of products to detect infectious and inflammatory eye conditions using rapid, lateral flow assays.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.